Compared with the control group, the outcomes revealed that N-cad, Vimentin, and Slug protein expression levels were remarkably reduced in the IPO5 gene silencing group (P < 0.05) (Figure 11), suggesting that IPO5 promotes the occurrence of EMT-induced esophageal cancer. The gene discussed is IPO5; the disease is esophageal cancer.